title: Ribavirin therapy for chronic hepatitis C does not modify HIV viral load in HIV-1 positive patients under antiretroviral treatment.
authors.affiliation: Infectious Diseases Department, San Raffaele Scientific Institute, Milan, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Morsica
authors.forename: A
authors.initials: A
authors.lastname: De Bona
authors.forename: C U
authors.initials: CU
authors.lastname: Foppa
authors.forename: G
authors.initials: G
authors.lastname: Sitia
authors.forename: R
authors.initials: R
authors.lastname: Finazzi
authors.forename: A
authors.initials: A
authors.lastname: Lazzarin
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000821:virology; D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D006679:HIV Seropositivity / Q000188:drug therapy / Q000821:virology; D015497:HIV-1 / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000097:blood; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use*; D019562:Viral Load
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D012367:RNA, Viral; D011994:Recombinant Proteins; D012254:Ribavirin